Orphan drug boom comes with a steady stream of outsourcing

With the FDA approving a record number of orphan drugs in 2014, sponsors weren’t the only ones to reap profits from their development.

https://www.outsourcing-pharma.com/Clinical-Development/Orphan-drug-boom-comes-with-a-steady-stream-of-outsourcing